Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Two specific genetic markers increase the risk of hair loss in Asian populations.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.

Women with PCOS have different hormone levels than those without it.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Human cells in plasma-derived gels can potentially mimic hair follicle environments, improving hair regeneration therapies.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

SHBG may be a useful early indicator and treatment target for PCOS.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Adding human fat-derived stem cells to hair follicle grafts greatly increases hair growth.

HGF activator helps convert HGF to its active form, promoting hair growth.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

Hirsutism and acne indicate high androgen levels in women with PCOS, suggesting early treatment can help.

Using umbilical cord stem cells can help create hair-growing tissues more affordably.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

PRP can help treat hair loss but needs standardized methods for best results.

Young women with PCOS without additional risk factors may have normal heart function.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.